Table 3 Contribution of 120 clinical isolates of P. aeruginosa to overall antimicrobial resistance rates
Classes/Antibiotics | Sensitive N (%) | Intermediate N (%) | Resistant N (%) | |
|---|---|---|---|---|
Cephalosporins | Cefepime | 26 (21.6) | 7 (5.8) | 87 (72.5) |
Ceftriaxone | 31 (25.8) | 9 (7.5) | 80 (66.6) | |
Cefoperazone | 29 (24.1) | 10 (8.3) | 81 (67.5) | |
Ceftazidime | 23 (19.1) | 7 (5.8) | 90 (75.0) | |
Aminoglycosides | Amikacin | 28 (23.3) | 10 (8.3) | 82 (68.3) |
Tobramycin | 31 (25.8) | 8 (6.6) | 81 (67.5) | |
Gentamycin | 29 (24.1) | 12 (10.0) | 79 (65.8) | |
Carbapenems | Imipenem | 30 (25.0) | 7 (5.8) | 83 (69.1) |
Ertapenem | 36 (30.0) | 10 (8.3) | 74 (61.6) | |
Meropenem | 47 (39.1) | 13 (10.8) | 60 (50.0) | |
Monobactams | Aztreonam | 36 (30.0) | 11 (9.1) | 73 (60.8) |
Fluoroquinolones | Levofloxacin | 38 (31.6) | 12 (10.0) | 70 (58.3) |
Ciprofloxacin | 51 (42.5) | 13 (10.8) | 56 (46.6) | |
Gatifloxacin | 35 (29.1) | 11 (9.1) | 74 (61.6) | |
Ofloxacin | 33 (27.5) | 15 (12.5) | 72 (60.0) | |
Penicillins | Piperacillin/tazobactam | 32 (26.6) | 9 (7.5) | 79 (65.8) |